Use of selegiline to prolong life span

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/135 (2006.01)

Patent

CA 2198217

Selegiline, or a pharmaceutically acceptable salt form of selegiline, is administered to mammals commencing at a point in time at which at least 50 % of the mammal's life span is completed, with the administration continuing on a periodic but regular basis over the remaining life span of the mammal. The treatment, which shifts the survival curve, is especially useful for dogs.

De la sélégiline, ou une forme sodée pharmaceutiquement acceptable de la sélégiline, est administrée à des mammifères. Cette administration débute lorsqu'au moins la moitié de la durée de vie du mammifère est écoulée, et se poursuit sur une base périodique mais régulière pendant la durée de vie restante du mammifère. Ce traitement modifiant la courbe de survie est notamment utile pour les chiens.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of selegiline to prolong life span does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of selegiline to prolong life span, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of selegiline to prolong life span will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1365158

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.